Review History

All reviews of published articles are made public. This includes manuscript files, peer review comments, author rebuttals and revised materials. Note: This was optional for articles submitted before 13 February 2023.

Peer reviewers are encouraged (but not required) to provide their names to the authors when submitting their peer review. If they agree to provide their name, then their personal profile page will reflect a public acknowledgment that they performed a review (even if the article is rejected). If the article is accepted, then reviewers who provided their name will be associated with the article itself.

View examples of open peer review.


  • The initial submission of this article was received on February 1st, 2016 and was peer-reviewed by 1 reviewer and the Academic Editor.
  • The Academic Editor made their initial decision on March 8th, 2016.
  • The first revision was submitted on April 1st, 2016 and was reviewed by the Academic Editor.
  • The article was Accepted by the Academic Editor on April 5th, 2016.

Version 0.2 (accepted)

· Apr 5, 2016 · Academic Editor


You addressed appropriately the concerns that had been raised by the reviewer and the Editor. I thank you for submitting your work to PeerJ.

Version 0.1 (original submission)

· Mar 8, 2016 · Academic Editor

Minor Revisions

Due to late external reviewers answers, we decided to not delay the evaluation of your ms and to base the decision on the assessment of one reviewer and myself, as I am sufficiently knowledgeable in the field.

Please address all the points raised, especially comments on validity of the findings. Include in this task also miR 338-3p (Wen C, Liu X, Ma H, Zhang W, Li H. Int J Oncol. 2015 May;46(5):2277-85). You should also comment on possible reasons why some experimentally observed miR targeting Runx2, e.g. miR-375 (Du et al, Exp Ther Med. 2015 Jul;10(1):207-212) , were not identified.


Basic reporting

1. While the overall manuscript is well written and clear, I would recommend the authors to consider re-writing the following two sentences:
a. Abstract: The first sentence of the abstract seems to imply microRNAs are only regulators of osteogenesis-related genes. It would be more correct to say: MicroRNAs (miRNAs) are small endogenous noncoding RNAs that play an instrumental role in post-transcriptional modulation of gene expression, including that of genes related to osteogenesis (i.e. RUNX2, COL1A1 and OSX).
b. Materials and Methods, Data Collection: The last sentence of this paragraph is difficult to understand. While I agree that the 3’UTR of the RUNX2 is 3777nts long, I do not understand what the authors mean when they say “The 3’UTR sequence of the RUNX2 gene is later the coding sequence region …”.
2. There is a significant lack of appropriate references in particular in the introduction, i.e. not a single reference is being provided in the first 1.5 paragraphs, and lack of references in the first couple of sentences of the discussion.
3. In my opinion, the authors should expand figure 2 to also include the additional selection criterion of minimal free energy. For completeness, not only the 70 initial candidates, but also the final 29 candidates that were then further evaluated using Sfold software should be listed in this figure and therefore presented to the reader in the main manuscript text.

Experimental design

The overall experimental design is sufficiently described.
However, the rationale for selecting RUNX2 as the target gene of interest in this study should be provided earlier than in the Conclusions, e.g. in the introduction or methods section.

Validity of the findings

This study provides a relevant strategy for combing several easily accessible prediction tools resulting in a robust and stringent selection process for the identification of relevant microRNA-mRNA interactions.
However, I feel in the discussion the authors should address in more detail the fact that miR-204 and miR-211 were identified, but filtered out by their approach although both have already been described in in vitro studies to be targeting RUNX2. What implications does this have for the validity of the proposed selection strategy? Did these two microRNAs for example only just not make the final cut-off of MFE and target accessibility?
Although the authors do acknowledge that in vitro and in vivo studies are required to further evaluate the accuracy of microRNA identification using prediction tools, I feel this point should be discussed in more detail on the example of miR-204/211.

All text and materials provided via this peer-review history page are made available under a Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.